Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics

Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics

Kimbach Tran Carpiuc1, Gianantonio Rosti2, Fausto Castagnetti2, Maarten Treur3, Jennifer Stephens11Pharmerit North America LLC, Bethesda, MD, USA; 2Department of Hematology and Oncology, S Orsola-Malpighi University Hospital, Bologna, Italy; 3Pharmerit Europe, Rotterdam, The NetherlandsAbstract: The...

Full description

Bibliographic Details
Main Authors: Kimbach Tran Carpiuc, Gianantonio Rosti, Fausto Castagnetti, et al
Format: Article
Language:English
Published: Dove Medical Press 2010-10-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/indirect-comparisons-of-second-generation-tyrosine-kinase-inhibitors-i-a5469

Internet

http://www.dovepress.com/indirect-comparisons-of-second-generation-tyrosine-kinase-inhibitors-i-a5469

Similar Items